Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab and Chemotherapy With or Without Radiotherapy in Advanced Squamous Cell Lung Cancer
NCT06121505Phase 2Recruiting
- Sponsor
- Sichuan University
- Start
- Mar 2024
- Primary completion
- Feb 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in squamous cell carcinoma of the lung (LSCC), sponsored by Sichuan University. Started Mar 2024; status: recruiting.
02
Drugs
sintilimab
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT06121505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06121505.